Novartis Cancels Vasella's $78M Golden Handshake
Feb. 19 (Bloomberg) -- Bloomberg Europe Business Editor Elliott Gotkine reports that Novartis and outgoing Chairman Daniel Vasella ended an agreement that would have paid him as much as $78 million to keep him from working for rival drugmakers. He speaks on Bloomberg Television's "The Pulse."
Most Recent Videos
Soylent: The Food of the Future?
31:27 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)